Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kristin B. Dupre"'
Autor:
Kristin B. Dupre, Ana V. Cruz, Alex J. McCoy, Claire Delaville, Colin M. Gerber, Katherine W. Eyring, Judith R. Walters
Publikováno v:
Neurobiology of Disease, Vol 86, Iss , Pp 1-15 (2016)
Prolonged L-dopa treatment in Parkinson's disease (PD) often leads to the expression of abnormal involuntary movements known as L-dopa-induced dyskinesia. Recently, dramatic 80 Hz oscillatory local field potential (LFP) activity within the primary mo
Externí odkaz:
https://doaj.org/article/39d10aa6a6c248a2a7348a494795f1d7
Autor:
Loren M. Frank, Jason E. Chung, Khara M. Ramos, Elizabeth Litvina, Samantha L. White, James P. Carson, Kristen M. Harris, Alison L. Barth, Kathleen M. Gates, Walter J. Koroshetz, Hannah Joo, James S. Trimmer, Amy Adams, Marcel P. Bruchez, Terrence J. Sejnowski, Kristin B. Dupre, Jeff W. Lichtman
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience. 39(42)
The overarching goal of the NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative is to advance the understanding of healthy and diseased brain circuit function through technological innovation. Core principles for this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720fed56c57225912a3511b5523291cf
https://pubmed.ncbi.nlm.nih.gov/31857357
https://pubmed.ncbi.nlm.nih.gov/31857357
Autor:
Colin M. Gerber, Claire Delaville, Judith R. Walters, Ana V. Cruz, Alex J. McCoy, Kristin B. Dupre, Katherine W. Eyring
Publikováno v:
Neurobiology of Disease, Vol 86, Iss, Pp 1-15 (2016)
Prolonged L-dopa treatment in Parkinson's disease (PD) often leads to the expression of abnormal involuntary movements known as L-dopa-induced dyskinesia. Recently, dramatic 80 Hz oscillatory local field potential (LFP) activity within the primary mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbed7cf9c668913d1aeb5360692f9451
https://doi.org/10.1016/j.nbd.2015.11.009
https://doi.org/10.1016/j.nbd.2015.11.009
Publikováno v:
Neuroscience. 310:12-26
Treatment of Parkinson’s disease (PD) with dopamine replacement relieves symptoms of poverty of movement, but often causes drug-induced dyskinesias. Accumulating clinical and pre-clinical evidence suggests that the primary motor cortex (M1) is invo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3801a3839131b6090bb52752b59506
https://doi.org/10.1016/j.neuroscience.2015.09.018
https://doi.org/10.1016/j.neuroscience.2015.09.018
Autor:
Alison L. Barth, Loren M. Frank, Elizabeth Litvina, James P. Carson, Marcel P. Bruchez, Hannah Joo, Terrence J. Sejnowski, Khara M. Ramos, Kristin B. Dupre, Kristen M. Harris, Jeff W. Lichtman, Amy Adams, Samantha L. White, Kathleen M. Gates, James S. Trimmer, Walter J. Koroshetz, Jason E. Chung
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience, vol 40, iss 2
The overarching goal of the NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative is to advance the understanding of healthy and diseased brain circuit function through technological innovation. Core principles for this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb766eb9083c3b23345215fdb2846b7
https://doi.org/10.1523/jneurosci.2721-19.2019
https://doi.org/10.1523/jneurosci.2721-19.2019
Autor:
Christopher Bishop, David Lindenbach, Karen L. Eskow Jaunarajs, Corinne Y. Ostock, Kristin B. Dupre, Adam A. Goldenberg
Publikováno v:
Brain Research. 1537:327-339
Motor symptoms of Parkinson's disease are commonly treated using l-DOPA although long-term treatment usually causes debilitating motor side effects including dyskinesias. A putative source of dyskinesia is abnormally high levels of phosphorylated ext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0c49cd1f1e9c582e318163fbd6cd0b
https://doi.org/10.1016/j.brainres.2013.09.020
https://doi.org/10.1016/j.brainres.2013.09.020
Autor:
Corinne Y. Ostock, Cara M. Hueston, Jessica A. George, Kristin B. Dupre, Karen L. Eskow Jaunarajs, Christopher Bishop
Publikováno v:
ACS Chemical Neuroscience. 4:747-760
Accumulating evidence supports the value of 5-HT1A receptor (5-HT1AR) agonists for dyskinesias that arise with long-term L-DOPA therapy in Parkinson's disease (PD). Yet, how 5-HT1AR stimulation directly influences the dyskinetogenic D1 receptor (D1R)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8931053967f28a7b3d59300035695ec9
https://doi.org/10.1021/cn300234z
https://doi.org/10.1021/cn300234z
Autor:
Catherine Kelly, Kristin B. Dupre, Karen L. Eskow Jaunarajs, Anna Klioueva, Aimee Steiniger, Christopher Bishop, Alexander Moore
Publikováno v:
NeuroReport. 20:1265-1269
Dopamine replacement therapy for the treatment of Parkinson's disease leads to deleterious abnormal involuntary movements (AIMs), known as L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia, which parallels enhanced striatal dopamine D1 recepto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ab4c31874f27b5532ec69a294247e5
https://doi.org/10.1097/wnr.0b013e3283300fd7
https://doi.org/10.1097/wnr.0b013e3283300fd7
Autor:
Christopher Bishop, Sando O. Dickinson, Christopher J. Barnum, John Y. Park, Karen L. Eskow, Kristin B. Dupre
Publikováno v:
Synapse. 63:610-620
Convergent evidence indicates that in later stages of Parkinson's disease raphestriatal serotonin neurons compensate for the loss of nigrostriatal dopamine neurons by converting and releasing dopamine derived from exogenous administration of the phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2b66421b9f121cb9945cbcf0cb19658
https://doi.org/10.1002/syn.20630
https://doi.org/10.1002/syn.20630
Publikováno v:
Neuropharmacology. 55:1321-1328
Convergent evidence suggests that serotonin 5-HT 1A receptor (5-HT 1A R) agonists reduce l -DOPA-induced dyskinesia by auto-regulating aberrant release of l -DOPA-derived dopamine (DA) from raphestriatal neurons. However, recent findings indicate tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f86508190fb95168fc49a4b47fd93ef
https://doi.org/10.1016/j.neuropharm.2008.08.031
https://doi.org/10.1016/j.neuropharm.2008.08.031